Averi Kit
Product Images NDC 75854-604
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Averi (NDC 75854-604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avion Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Averi 3-cycle Carton (Averi 10)
Figure 1 (Averi 2)
This text provides information on Circulatory Disease Mortality Rates per 100,000 Women-Years by Age, focusing on Smoking Status and Oral Contraceptive Use. The data includes mortality rates for users and non-users of oral contraceptives, as well as controls who are smokers or non-smokers. The source of the information is P.M. Layde and V. Beral, reference #12.*
Table 2 (Averi 3)
The text provided is a table showing the annual number of birth-related or method-related deaths associated with the control of fertility per 100,000 nonsterile women, categorized by fertility control method and age group. It includes data on various methods such as no fertility control methods, oral contraceptives for non-smokers and smokers, IUD, condom, diaphragm/spermicide, and periodic abstinence. The table contains mortality rates per 100,000 women for different age groups (15-19, 20-24, 25-29, 30-34, 35-39, 40-44). The information is important for analyzing the safety and effectiveness of different fertility control methods in relation to birth-related or method-related deaths.*
Figure 2 (Averi 4)
This text provides information about the risk of breast cancer associated with combined oral contraceptive (COC) use from various studies conducted between 2002 and 2017. The studies mentioned include the NICHD Wamer Contraceptive Study, French E3N cohort study, Shanghai Women's Health Study, Nurses' Health Study, Outord Family Planning Association Study, and Danish Sex Hormone Registry study. The text also includes definitions of terms such as RR (relative risk), OR (odds ratio), and HR (hazard ratio), along with categories of COC use like "ever COC use" and "never COC use" for females. This information can help in understanding the implications of combined oral contraceptive use in relation to breast cancer risk.*
Avion Logo (Averi 5)
Ifu Image 1 (Averi 6)
Ifu Image 2 (Averi 7)
Avion Logo (Averi 8)
Averi 1-cycle Carton (Averi 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.